VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
QNRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
QNRXQuoin Pharmaceuticals, Ltd.
$4.80$9M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksQNRXQuarterly Financials

Quoin Pharmaceuticals, Ltd. (QNRX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Quoin Pharmaceuticals, Ltd. (QNRX) quarterly income statement — complete revenue, gross profit & net income history

QNRX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold24.93K0000000000000000000
COGS % of Revenue--------------------
Gross Profit-24.93K0000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses5.09M4.52M4.02M3.79M3.96M2.41M2.53M2.14M2.46M2.22M2.13M2.26M2.78M2.09M2.33M2.67M2.18M2.98M1.3M976.89K
OpEx % of Revenue--------------------
Selling, General & Admin1.69M1.42M1.74M1.74M1.58M1.33M1.36M1.55M1.57M1.39M1.37M1.63M1.68M1.47M1.58M1.94M1.59M1.97M1.04M737.61K
SG&A % of Revenue--------------------
Research & Development3.4M3.1M2.28M2.05M2.37M1.07M1.17M587.5K885.3K832.39K758.76K625.1K1.09M613.07K745.51K726.69K587.57K1.01M260K239.28K
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-5.12M-4.52M-4.02M-3.79M-3.96M-2.41M-2.53M-2.14M-2.46M-2.22M-2.13M-2.26M-2.78M-2.09M-2.33M-2.67M-2.18M-2.98M-1.3M-976.89K
Operating Margin %--------------------
Operating Income Growth %-29.32%-87.96%-59.02%-77.49%-60.97%-8.45%-18.95%5.44%11.43%-6.32%8.69%15.3%-27.55%30.04%-78.66%-173.13%-171.41%-402.82%--
EBITDA-5.09M-4.5M-3.99M-3.77M-3.93M-2.38M-2.5M-2.11M-2.43M-2.19M-2.1M-2.23M-2.75M-2.06M-2.3M-2.64M-2.15M-2.96M-1.28M-950.88K
EBITDA Margin %--------------------
EBITDA Growth %-29.51%-88.88%-59.61%-78.41%-61.6%-8.58%-19.24%5.46%11.5%-6.41%8.79%15.45%-27.88%30.3%-80.26%-177.86%-177.15%-421.3%--
D&A (Non-Cash Add-back)24.93K25K25K25K25K25K25K25K25K25.67K26.01K26.01K26.01K26.01K26.01K26.01K26.01K26.01K26.01K26.01K
EBIT-5.12M-4.52M-3.95M-3.79M-3.96M-2.41M-2.53M-2.14M-2.46M-2.05M-2.13M-2.26M-2.78M-2M-2.32M-2.67M-2.18M-11.24M-1.16M-4.14M
Net Interest Income146.38K171.7K0105.39K144.87K109.33K146.39K165.26K137.51K158.55K196.43K187.59K152.05K80.61K-698.95K00-574.13K-248.16K-202.51K
Interest Income146.38K171.7K0105.39K144.87K109.33K146.39K165.26K137.51K158.55K196.43K187.59K152.05K80.61K15.13K00000
Interest Expense00000000000000714.08K00574.13K248.16K202.51K
Other Income/Expense133.11K172.06K71.76K97.24K145K93.79K178.12K163.09K131K167.79K198.54K153.12K172.48K84.97K-702K0493.24K-8.84M-101.36K-3.36M
Pretax Income-4.98M-4.35M-3.95M-3.7M-3.81M-2.31M-2.35M-1.97M-2.33M-2.05M-1.93M-2.11M-2.6M-2M-3.03M-2.67M-1.68M-11.82M-1.4M-4.34M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-4.98M-4.35M-3.95M-3.7M-3.81M-2.31M-2.35M-1.97M-2.33M-2.05M-1.93M-2.11M-2.6M-2M-3.03M-2.67M-1.68M-11.82M-1.4M-4.34M
Net Margin %--------------------
Net Income Growth %-30.74%-88.14%-68.02%-87.23%-63.8%-12.75%-21.97%6.31%10.59%-2.44%36.4%21.03%-54.69%83.07%-115.76%38.49%56.89%-1060.47%--
Net Income (Continuing)-4.98M-4.35M-3.95M-3.7M-3.81M-2.31M-2.35M-1.97M-2.33M-2.05M-1.93M-2.11M-2.6M-2M-3.03M-2.67M-1.68M-11.82M-1.4M-4.34M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-2.54-2.92-6.71-6.28-6.50-12.41-16.45-0.39-1.12-2.10-1.95-2.13-2.42-4.89-13.64-9.72-21.27-474659.72-70.11-216.57
EPS Growth %60.92%76.47%59.21%-1510.26%-480.36%-490.95%-743.59%81.69%53.72%57.06%85.7%78.09%88.62%100%80.54%95.51%89.09%-3731501.57%--
EPS (Basic)-2.54-2.92-6.71-6.28-6.50-12.37-16.45-0.39-1.12-2.10-1.95-2.13-2.42-4.89-13.64-9.72-21.28-476811.52-70.21-216.88
Diluted Shares Outstanding1.96M1.5M588.17K588.17K586.33K186.51K5M5.05M2.1M987.22K987.22K987.22K987.22K403.88K274.37K274.37K55.92K45.2K20.03K20.03K
Basic Shares Outstanding1.96M1.5M588.17K588.17K586.33K186.51K5M5.05M2.1M987.22K987.22K987.22K987.22K403.88K274.37K274.37K55.91K45K20K20K
Dividend Payout Ratio--------------------